PUMA BIOTECHNOLOGY, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2020 | $95.8M | $9.4M | $83.4M |
| Jun 2020 | $96.6M | $23.4M | $90.9M |
| Sep 2020 | $91.7M | $-453.0K | $90.1M |
| Dec 2020 | $84.0M | $-6.0M | $85.3M |
| Mar 2021 | $76.3M | $16.3M | $95.7M |
| Jun 2021 | $68.7M | $29.5M | $89.8M |
| Sep 2021 | $96.8M | $-10.9M | $63.9M |
| Dec 2021 | $97.1M | $-2.4M | $63.1M |
| Mar 2022 | $97.4M | $7.1M | $63.9M |
| Jun 2022 | $97.7M | $19.7M | $52.8M |
| Sep 2022 | $98.0M | $22.2M | $78.0M |
| Dec 2022 | $98.3M | $21.6M | $76.2M |
| Mar 2023 | $98.6M | $25.8M | $61.4M |
| Jun 2023 | $87.6M | $30.4M | $60.0M |
| Sep 2023 | $76.6M | $38.7M | $81.8M |
| Dec 2023 | $65.7M | $53.4M | $84.6M |
| Mar 2024 | $54.7M | $51.0M | $76.8M |
| Jun 2024 | $43.7M | $48.5M | $67.1M |
| Sep 2024 | $32.7M | $71.1M | $67.3M |
| Dec 2024 | $21.7M | $92.1M | $69.2M |